Authors
Loading...
Randomized trial demonstrates the impact of HK2 knockdown on inflammatory and angiogenesis pathways in glioblastoma, suggesting new therapeutic strategies.
Edwards et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: